Wixler V, Smola U, Schuler M, Rapp U
Institute of Medical Radiation and Cell Research, Bayerisch, Julius-Maximillians-Universität, Würzburg, Germany.
FEBS Lett. 1996 May 6;385(3):131-7. doi: 10.1016/0014-5793(96)00363-8.
PC12 pheochromocytoma cells possess four known MEK activators: A-, B-, c-Raf-1 and MEKK. In order to examine whether differentiation factors or growth factors have a Raf isozyme preference for activation of the mitogenic cytoplasmic Raf-MEK-MAPK protein kinase cascade, the activation kinetics of these enzymes in response to epidermal growth factor (EGF) and nerve growth factor (NGF) were compared. An initial activation of all three Raf kinases was noticed, but only A- and B-Raf showed sustained activation by NGF, which was not seen after EGF treatment. Furthermore, expression of oncogenic versions of all three Raf kinases as well, as a potentially Raf-independent MEK activator, v-Mos, leads to activation of MAPK and to differentiation of PC12 cells. These data suggest a differential regulation of Raf kinases and that probably no alternative Raf substrates are involved in differentiation processes of PC12 cells.
PC12嗜铬细胞瘤细胞拥有四种已知的MEK激活剂:A-Raf、B-Raf、c-Raf-1和MEKK。为了研究分化因子或生长因子在激活有丝分裂细胞质Raf-MEK-MAPK蛋白激酶级联反应时是否对Raf同工酶有偏好,比较了这些酶对表皮生长因子(EGF)和神经生长因子(NGF)反应的激活动力学。注意到所有三种Raf激酶都有初始激活,但只有A-Raf和B-Raf在NGF作用下表现出持续激活,而在EGF处理后未观察到这种情况。此外,所有三种Raf激酶的致癌形式以及一种可能不依赖Raf的MEK激活剂v-Mos的表达,都会导致MAPK激活和PC12细胞分化。这些数据表明Raf激酶存在差异调节,并且在PC12细胞的分化过程中可能不涉及其他Raf底物。